& quot; We dé cid & eacute; proc & eacute; der ind é analysis, pending, without bias, the m & eacute; drugs in France, their dé development, their dé evaluation, their good and their bad use. & quot ; Thus four & quot; Patterns & quot; m & eacute; medicine, aid & eacute; s with 28 other sp & eacute; ists explain, in a book published * & eacute; Thursday, wanting r & eacute; establish LA v & eacute; rit & eacute; an area that is much written.
Professors Jean – Fran & ccedil ; ois Bergmann, Fran & ccedil ; ois Chast, Andr & eacute; Grimaldi and Claire Le Jeunne pr & eacute; cisent the opportunity that the subject is too vast to & ecirc ; ma & be icirc ; tris & eacute; by one man or two, making r & eacute; f & eacute; rence other works r & eacute; recently published & eacute; s..
One of their goals is to restore the confidence of patients.
For this, we must not h & eacute; siter introduce topics f & acirc ; Chent.
For example r & eacute; r & lay a question eacute; currente : industrial – they invent new diseases to find dé bouch & eacute; s ? Their & quot; g & eacute; denies inventive & quot; is underlined & eacute; by the authors, explaining that when the market & eacute; is too small, there is a temptation of dé broaden & quot; Various fa & ccedil ; ons, more or less artificial & quot;.
They dé crivent : from symptoms & OCIRC ; my non sp & eacute; cific, we can cr & eacute; er disease.
Using conf & eacute; consensus ences, expert groups, incentives, more or less deaf, we invent a concept that becomes a disease corresponding m & eacute; dicament.
Collusion between industry and some sp & eacute; ists leaders.
There & quot; dissatisfaction f & eacute; minine & quot; who & eacute; t & eacute; dé written upstream of the placing on the market & eacute; – Am dé Rican – testost of patches & eacute ; rone to try and am dé improve.
The & quot; Prostatism & quot; matches the symptoms & OCIRC and my urinary felt in patients with an ad & eacute; nome of the prostate, but this time reached the men who do not have ad & eacute; nome ! Imm & eacute; ately, anyone who has a little trouble urinating is concerned & eacute; and symptoms & OCIRC vague is treated me & eacute; as if c ‘& eacute; was a disease.
& quot; We can also artificially increase the en & eacute; frequency of pathology & quot ;, the authors added, citing the so-called & quot disease Restless Legs & quot;.
This condition, considered & eacute; r & eacute; e as exceptional, manifested by & quot; Tr & eacute; mulations & quot; permanent members inf & eacute; EXTERIORFEATURES, especially at night, which is extr & ecirc ; g & ecirc armament ; ing.
D & egrave ; s that m & eacute; drugs have & eacute; t & eacute; developed the dé finishing the disease has become blurred, and multiplying by one hundred the number of b & eacute; n & eacute; potential beneficiaries of these treatments.
Finally, dé broaden the market & eacute ;, it is possible to lower the threshold d & eacute ; finishing diseases.
The authors’ conclusion is clear: & quot; In all cases, there is a collusion between industry and some sp & eacute; ists leaders who like to increase their activity & eacute; increasing en & eacute; frequency of diseases they support. & quot ; In short, responsibility & eacute; s are shared & eacute; es.
As for the patients, they are not dé spared & eacute; s, because they always require more m & eacute; drugs and mol & eacute; r & eacute most particles ; Centes.
But too often, they do not correctly follow the prescribed treatments.
Content) // ]] & gt; * & Quot; The V & eacute; rit & eacute; your m & eacute; drugs & quot ;, Editions Odile Jacob, 590 pages, 23.90 euros.